nasdaq-mynz-mainzbiomed.png
Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland
December 12, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers
December 05, 2023 09:01 ET | Mainz BioMed NV
Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers
nasdaq-mynz-mainzbiomed.png
Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast
November 29, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference
November 20, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 16, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering
November 15, 2023 09:01 ET | Mainz BioMed NV
Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering
November 13, 2023 09:00 ET | Mainz BioMed NV
Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
November 09, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
November 07, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper
October 31, 2023 08:01 ET | Mainz BioMed NV
Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper